Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU

Inflammatory pouch disorders exhibit a heterogeneous clinical spectrum and therapeutic requirements have not been properly studied. This retrospective, multicentre study included ulcerative colitis patients with ileal pouch construction and were later diagnosed with an inflammatory pouch disorder be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive and liver disease 2025-02, Vol.57 (2), p.566-573
Hauptverfasser: Mesonero, F., Zabana, Y., Fernández-Clotet, A., Solá, A., Caballol, B., Leo-Carnerero, E., García, M.J., Bertoletti, F., Bastida, G., Suris, G., Casis, B., Ferreiro-Iglesias, R., Calafat, M., Jiménez, I., Miranda-Bautista, J., Lamuela, L.J., Fajardo, I., Torrealba, L., Nájera, R., Sáiz-Chumillas, R.M., González-Partida, I., Vicuña, M., García-Morales, N., Gutiérrez, A., López-García, A., Benítez, J.M., Rubín de Célix, C., Tejido, C., Brunet, E., Hernandez-Camba, A., Suárez, C., Rodríguez-Lago, I., Piqueras, M., Castaño, A., Ramos, L., Sobrino, A., Rodríguez-Grau, M.C., Elosua, A., Montoro, M., Baltar, R., Huguet, J.M., Hermida, B., Caballero-Mateos, A., Sánchez-Guillén, L., Bouhmidi, A., Pajares, R., Baston-Rey, I., López-Sanromán, A., Albillos, A., Barreiro-de Acosta, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 573
container_issue 2
container_start_page 566
container_title Digestive and liver disease
container_volume 57
creator Mesonero, F.
Zabana, Y.
Fernández-Clotet, A.
Solá, A.
Caballol, B.
Leo-Carnerero, E.
García, M.J.
Bertoletti, F.
Bastida, G.
Suris, G.
Casis, B.
Ferreiro-Iglesias, R.
Calafat, M.
Jiménez, I.
Miranda-Bautista, J.
Lamuela, L.J.
Fajardo, I.
Torrealba, L.
Nájera, R.
Sáiz-Chumillas, R.M.
González-Partida, I.
Vicuña, M.
García-Morales, N.
Gutiérrez, A.
López-García, A.
Benítez, J.M.
Rubín de Célix, C.
Tejido, C.
Brunet, E.
Hernandez-Camba, A.
Suárez, C.
Rodríguez-Lago, I.
Piqueras, M.
Castaño, A.
Ramos, L.
Sobrino, A.
Rodríguez-Grau, M.C.
Elosua, A.
Montoro, M.
Baltar, R.
Huguet, J.M.
Hermida, B.
Caballero-Mateos, A.
Sánchez-Guillén, L.
Bouhmidi, A.
Pajares, R.
Baston-Rey, I.
López-Sanromán, A.
Albillos, A.
Barreiro-de Acosta, M.
description Inflammatory pouch disorders exhibit a heterogeneous clinical spectrum and therapeutic requirements have not been properly studied. This retrospective, multicentre study included ulcerative colitis patients with ileal pouch construction and were later diagnosed with an inflammatory pouch disorder between 1995 and 2020. Classifications, behaviour and therapies applied were recorded and compared in the long-term. Overall, 338 patients were recruited. The most common disorders were pouchitis (n = 258, 76%), Crohn's disease of the pouch (n = 55, 16%) and cuffitis (n = 25, 7%). Pouchitis presented mainly as chronic (65.2%) and recurrent (87%) forms. Crohn's disease manifested as stricturing/penetrating in 53% of cases and perianal disease in 42%. Patients received multiple therapies: 86% antibiotics, 42% steroids, 27% immunosuppressants, 43% biologics and 27% surgery. Compared with pouchitis, Crohn's disease of the pouch was characterised by a later diagnosis (99 vs. 55 months, p < 0.001) and greater needs for immunosuppressants (OR 3.53, 1.79–6.94, p < 0.0001), biologics (OR 5.45, 2.78–10.6, p < 0.0001) and surgeries (OR 2.65, 1.43–4.89, p < 0.001). Chronic pouchitis is the most common pouch disorder presentation. These entities have diverse therapeutics requirements, particularly for Crohn's disease of the pouch.
doi_str_mv 10.1016/j.dld.2024.09.023
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3121059732</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1590865824010235</els_id><sourcerecordid>3121059732</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1503-df934c6b6ab45faed82abd52a46876173b564995289e1448183213d3a1f36d803</originalsourceid><addsrcrecordid>eNp9kEtr3DAURk1pyav5Ad0ULbuoHT0sjdyuwuCmgUBgOulWyNI1o8G2HMkKnX9fDZNm2ZXu4nwHdIriE8EVwUTc7Cs72IpiWle4qTBl74oLIleyZFzQ9_nmDS6l4PK8uIxxjzElguOz4pw1NeeMsIviz_YwQ_yKOtjpF-dTQHqyaNlB0DOkxRkU4Dm5ACNMS0S-R27qBz2OevHhgGafzA5ZF32wEOI3tIGYhgz2wY9HDdq0v9rN70cUl2QPx_1du23X66ePxYdeDxGuX9-r4ulHu13_LB8e7-7Xtw-lIRyz0vYNq43ohO5q3muwkurOcqprIVeCrFjHRd00nMoGSF1LIhklzDJNeiasxOyq-HLyzsE_J4iLGl00MAx6Ap-iYoQSzJsVoxklJ9QEH2OAXs3BjTocFMHqGFztVQ6ujsEVblQOnjefX_WpG8G-Lf4VzsD3EwD5ky8OgorGwWTA5qhmUda7_-j_AogrkIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3121059732</pqid></control><display><type>article</type><title>Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mesonero, F. ; Zabana, Y. ; Fernández-Clotet, A. ; Solá, A. ; Caballol, B. ; Leo-Carnerero, E. ; García, M.J. ; Bertoletti, F. ; Bastida, G. ; Suris, G. ; Casis, B. ; Ferreiro-Iglesias, R. ; Calafat, M. ; Jiménez, I. ; Miranda-Bautista, J. ; Lamuela, L.J. ; Fajardo, I. ; Torrealba, L. ; Nájera, R. ; Sáiz-Chumillas, R.M. ; González-Partida, I. ; Vicuña, M. ; García-Morales, N. ; Gutiérrez, A. ; López-García, A. ; Benítez, J.M. ; Rubín de Célix, C. ; Tejido, C. ; Brunet, E. ; Hernandez-Camba, A. ; Suárez, C. ; Rodríguez-Lago, I. ; Piqueras, M. ; Castaño, A. ; Ramos, L. ; Sobrino, A. ; Rodríguez-Grau, M.C. ; Elosua, A. ; Montoro, M. ; Baltar, R. ; Huguet, J.M. ; Hermida, B. ; Caballero-Mateos, A. ; Sánchez-Guillén, L. ; Bouhmidi, A. ; Pajares, R. ; Baston-Rey, I. ; López-Sanromán, A. ; Albillos, A. ; Barreiro-de Acosta, M.</creator><creatorcontrib>Mesonero, F. ; Zabana, Y. ; Fernández-Clotet, A. ; Solá, A. ; Caballol, B. ; Leo-Carnerero, E. ; García, M.J. ; Bertoletti, F. ; Bastida, G. ; Suris, G. ; Casis, B. ; Ferreiro-Iglesias, R. ; Calafat, M. ; Jiménez, I. ; Miranda-Bautista, J. ; Lamuela, L.J. ; Fajardo, I. ; Torrealba, L. ; Nájera, R. ; Sáiz-Chumillas, R.M. ; González-Partida, I. ; Vicuña, M. ; García-Morales, N. ; Gutiérrez, A. ; López-García, A. ; Benítez, J.M. ; Rubín de Célix, C. ; Tejido, C. ; Brunet, E. ; Hernandez-Camba, A. ; Suárez, C. ; Rodríguez-Lago, I. ; Piqueras, M. ; Castaño, A. ; Ramos, L. ; Sobrino, A. ; Rodríguez-Grau, M.C. ; Elosua, A. ; Montoro, M. ; Baltar, R. ; Huguet, J.M. ; Hermida, B. ; Caballero-Mateos, A. ; Sánchez-Guillén, L. ; Bouhmidi, A. ; Pajares, R. ; Baston-Rey, I. ; López-Sanromán, A. ; Albillos, A. ; Barreiro-de Acosta, M. ; On behalf of the GETECCU Young Members Group ; GETECCU Young Members Group</creatorcontrib><description>Inflammatory pouch disorders exhibit a heterogeneous clinical spectrum and therapeutic requirements have not been properly studied. This retrospective, multicentre study included ulcerative colitis patients with ileal pouch construction and were later diagnosed with an inflammatory pouch disorder between 1995 and 2020. Classifications, behaviour and therapies applied were recorded and compared in the long-term. Overall, 338 patients were recruited. The most common disorders were pouchitis (n = 258, 76%), Crohn's disease of the pouch (n = 55, 16%) and cuffitis (n = 25, 7%). Pouchitis presented mainly as chronic (65.2%) and recurrent (87%) forms. Crohn's disease manifested as stricturing/penetrating in 53% of cases and perianal disease in 42%. Patients received multiple therapies: 86% antibiotics, 42% steroids, 27% immunosuppressants, 43% biologics and 27% surgery. Compared with pouchitis, Crohn's disease of the pouch was characterised by a later diagnosis (99 vs. 55 months, p &lt; 0.001) and greater needs for immunosuppressants (OR 3.53, 1.79–6.94, p &lt; 0.0001), biologics (OR 5.45, 2.78–10.6, p &lt; 0.0001) and surgeries (OR 2.65, 1.43–4.89, p &lt; 0.001). Chronic pouchitis is the most common pouch disorder presentation. These entities have diverse therapeutics requirements, particularly for Crohn's disease of the pouch.</description><identifier>ISSN: 1590-8658</identifier><identifier>ISSN: 1878-3562</identifier><identifier>EISSN: 1878-3562</identifier><identifier>DOI: 10.1016/j.dld.2024.09.023</identifier><identifier>PMID: 39455313</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adult ; Anti-Bacterial Agents - therapeutic use ; Colitis, Ulcerative - drug therapy ; Colitis, Ulcerative - surgery ; Colitis, Ulcerative - therapy ; Colonic Pouches - adverse effects ; Crohn Disease - drug therapy ; Crohn's disease of the pouch ; Cuffitis ; Female ; Humans ; Immunosuppressive Agents - therapeutic use ; Italy ; Male ; Middle Aged ; Pouchitis ; Pouchitis - drug therapy ; Pouchitis - therapy ; Proctocolectomy, Restorative - adverse effects ; Retrospective Studies</subject><ispartof>Digestive and liver disease, 2025-02, Vol.57 (2), p.566-573</ispartof><rights>2024 Editrice Gastroenterologica Italiana S.r.l.</rights><rights>Copyright © 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1503-df934c6b6ab45faed82abd52a46876173b564995289e1448183213d3a1f36d803</cites><orcidid>0000-0002-1729-6472 ; 0000-0003-0623-9074 ; 0000-0001-6097-7612 ; 0000-0002-7921-6730 ; 0000-0001-7544-451X ; 0000-0001-7676-9842 ; 0000-0002-5460-4139 ; 0000-0002-3874-2638 ; 0000-0001-8898-3141 ; 0000-0002-6517-7005 ; 0000-0002-0469-4332 ; 0000-0003-1133-4578 ; 0000-0002-8120-2485 ; 0000-0001-9539-1689 ; 0000-0001-8661-0608 ; 0000-0001-7513-0764 ; 0000-0003-0130-3778 ; 0000-0002-3425-7758 ; 0000-0002-7864-8187 ; 0000-0003-2335-3792 ; 0000-0002-6006-8328</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1590865824010235$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39455313$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mesonero, F.</creatorcontrib><creatorcontrib>Zabana, Y.</creatorcontrib><creatorcontrib>Fernández-Clotet, A.</creatorcontrib><creatorcontrib>Solá, A.</creatorcontrib><creatorcontrib>Caballol, B.</creatorcontrib><creatorcontrib>Leo-Carnerero, E.</creatorcontrib><creatorcontrib>García, M.J.</creatorcontrib><creatorcontrib>Bertoletti, F.</creatorcontrib><creatorcontrib>Bastida, G.</creatorcontrib><creatorcontrib>Suris, G.</creatorcontrib><creatorcontrib>Casis, B.</creatorcontrib><creatorcontrib>Ferreiro-Iglesias, R.</creatorcontrib><creatorcontrib>Calafat, M.</creatorcontrib><creatorcontrib>Jiménez, I.</creatorcontrib><creatorcontrib>Miranda-Bautista, J.</creatorcontrib><creatorcontrib>Lamuela, L.J.</creatorcontrib><creatorcontrib>Fajardo, I.</creatorcontrib><creatorcontrib>Torrealba, L.</creatorcontrib><creatorcontrib>Nájera, R.</creatorcontrib><creatorcontrib>Sáiz-Chumillas, R.M.</creatorcontrib><creatorcontrib>González-Partida, I.</creatorcontrib><creatorcontrib>Vicuña, M.</creatorcontrib><creatorcontrib>García-Morales, N.</creatorcontrib><creatorcontrib>Gutiérrez, A.</creatorcontrib><creatorcontrib>López-García, A.</creatorcontrib><creatorcontrib>Benítez, J.M.</creatorcontrib><creatorcontrib>Rubín de Célix, C.</creatorcontrib><creatorcontrib>Tejido, C.</creatorcontrib><creatorcontrib>Brunet, E.</creatorcontrib><creatorcontrib>Hernandez-Camba, A.</creatorcontrib><creatorcontrib>Suárez, C.</creatorcontrib><creatorcontrib>Rodríguez-Lago, I.</creatorcontrib><creatorcontrib>Piqueras, M.</creatorcontrib><creatorcontrib>Castaño, A.</creatorcontrib><creatorcontrib>Ramos, L.</creatorcontrib><creatorcontrib>Sobrino, A.</creatorcontrib><creatorcontrib>Rodríguez-Grau, M.C.</creatorcontrib><creatorcontrib>Elosua, A.</creatorcontrib><creatorcontrib>Montoro, M.</creatorcontrib><creatorcontrib>Baltar, R.</creatorcontrib><creatorcontrib>Huguet, J.M.</creatorcontrib><creatorcontrib>Hermida, B.</creatorcontrib><creatorcontrib>Caballero-Mateos, A.</creatorcontrib><creatorcontrib>Sánchez-Guillén, L.</creatorcontrib><creatorcontrib>Bouhmidi, A.</creatorcontrib><creatorcontrib>Pajares, R.</creatorcontrib><creatorcontrib>Baston-Rey, I.</creatorcontrib><creatorcontrib>López-Sanromán, A.</creatorcontrib><creatorcontrib>Albillos, A.</creatorcontrib><creatorcontrib>Barreiro-de Acosta, M.</creatorcontrib><creatorcontrib>On behalf of the GETECCU Young Members Group</creatorcontrib><creatorcontrib>GETECCU Young Members Group</creatorcontrib><title>Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU</title><title>Digestive and liver disease</title><addtitle>Dig Liver Dis</addtitle><description>Inflammatory pouch disorders exhibit a heterogeneous clinical spectrum and therapeutic requirements have not been properly studied. This retrospective, multicentre study included ulcerative colitis patients with ileal pouch construction and were later diagnosed with an inflammatory pouch disorder between 1995 and 2020. Classifications, behaviour and therapies applied were recorded and compared in the long-term. Overall, 338 patients were recruited. The most common disorders were pouchitis (n = 258, 76%), Crohn's disease of the pouch (n = 55, 16%) and cuffitis (n = 25, 7%). Pouchitis presented mainly as chronic (65.2%) and recurrent (87%) forms. Crohn's disease manifested as stricturing/penetrating in 53% of cases and perianal disease in 42%. Patients received multiple therapies: 86% antibiotics, 42% steroids, 27% immunosuppressants, 43% biologics and 27% surgery. Compared with pouchitis, Crohn's disease of the pouch was characterised by a later diagnosis (99 vs. 55 months, p &lt; 0.001) and greater needs for immunosuppressants (OR 3.53, 1.79–6.94, p &lt; 0.0001), biologics (OR 5.45, 2.78–10.6, p &lt; 0.0001) and surgeries (OR 2.65, 1.43–4.89, p &lt; 0.001). Chronic pouchitis is the most common pouch disorder presentation. These entities have diverse therapeutics requirements, particularly for Crohn's disease of the pouch.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Colitis, Ulcerative - surgery</subject><subject>Colitis, Ulcerative - therapy</subject><subject>Colonic Pouches - adverse effects</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn's disease of the pouch</subject><subject>Cuffitis</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Italy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pouchitis</subject><subject>Pouchitis - drug therapy</subject><subject>Pouchitis - therapy</subject><subject>Proctocolectomy, Restorative - adverse effects</subject><subject>Retrospective Studies</subject><issn>1590-8658</issn><issn>1878-3562</issn><issn>1878-3562</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtr3DAURk1pyav5Ad0ULbuoHT0sjdyuwuCmgUBgOulWyNI1o8G2HMkKnX9fDZNm2ZXu4nwHdIriE8EVwUTc7Cs72IpiWle4qTBl74oLIleyZFzQ9_nmDS6l4PK8uIxxjzElguOz4pw1NeeMsIviz_YwQ_yKOtjpF-dTQHqyaNlB0DOkxRkU4Dm5ACNMS0S-R27qBz2OevHhgGafzA5ZF32wEOI3tIGYhgz2wY9HDdq0v9rN70cUl2QPx_1du23X66ePxYdeDxGuX9-r4ulHu13_LB8e7-7Xtw-lIRyz0vYNq43ohO5q3muwkurOcqprIVeCrFjHRd00nMoGSF1LIhklzDJNeiasxOyq-HLyzsE_J4iLGl00MAx6Ap-iYoQSzJsVoxklJ9QEH2OAXs3BjTocFMHqGFztVQ6ujsEVblQOnjefX_WpG8G-Lf4VzsD3EwD5ky8OgorGwWTA5qhmUda7_-j_AogrkIw</recordid><startdate>202502</startdate><enddate>202502</enddate><creator>Mesonero, F.</creator><creator>Zabana, Y.</creator><creator>Fernández-Clotet, A.</creator><creator>Solá, A.</creator><creator>Caballol, B.</creator><creator>Leo-Carnerero, E.</creator><creator>García, M.J.</creator><creator>Bertoletti, F.</creator><creator>Bastida, G.</creator><creator>Suris, G.</creator><creator>Casis, B.</creator><creator>Ferreiro-Iglesias, R.</creator><creator>Calafat, M.</creator><creator>Jiménez, I.</creator><creator>Miranda-Bautista, J.</creator><creator>Lamuela, L.J.</creator><creator>Fajardo, I.</creator><creator>Torrealba, L.</creator><creator>Nájera, R.</creator><creator>Sáiz-Chumillas, R.M.</creator><creator>González-Partida, I.</creator><creator>Vicuña, M.</creator><creator>García-Morales, N.</creator><creator>Gutiérrez, A.</creator><creator>López-García, A.</creator><creator>Benítez, J.M.</creator><creator>Rubín de Célix, C.</creator><creator>Tejido, C.</creator><creator>Brunet, E.</creator><creator>Hernandez-Camba, A.</creator><creator>Suárez, C.</creator><creator>Rodríguez-Lago, I.</creator><creator>Piqueras, M.</creator><creator>Castaño, A.</creator><creator>Ramos, L.</creator><creator>Sobrino, A.</creator><creator>Rodríguez-Grau, M.C.</creator><creator>Elosua, A.</creator><creator>Montoro, M.</creator><creator>Baltar, R.</creator><creator>Huguet, J.M.</creator><creator>Hermida, B.</creator><creator>Caballero-Mateos, A.</creator><creator>Sánchez-Guillén, L.</creator><creator>Bouhmidi, A.</creator><creator>Pajares, R.</creator><creator>Baston-Rey, I.</creator><creator>López-Sanromán, A.</creator><creator>Albillos, A.</creator><creator>Barreiro-de Acosta, M.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1729-6472</orcidid><orcidid>https://orcid.org/0000-0003-0623-9074</orcidid><orcidid>https://orcid.org/0000-0001-6097-7612</orcidid><orcidid>https://orcid.org/0000-0002-7921-6730</orcidid><orcidid>https://orcid.org/0000-0001-7544-451X</orcidid><orcidid>https://orcid.org/0000-0001-7676-9842</orcidid><orcidid>https://orcid.org/0000-0002-5460-4139</orcidid><orcidid>https://orcid.org/0000-0002-3874-2638</orcidid><orcidid>https://orcid.org/0000-0001-8898-3141</orcidid><orcidid>https://orcid.org/0000-0002-6517-7005</orcidid><orcidid>https://orcid.org/0000-0002-0469-4332</orcidid><orcidid>https://orcid.org/0000-0003-1133-4578</orcidid><orcidid>https://orcid.org/0000-0002-8120-2485</orcidid><orcidid>https://orcid.org/0000-0001-9539-1689</orcidid><orcidid>https://orcid.org/0000-0001-8661-0608</orcidid><orcidid>https://orcid.org/0000-0001-7513-0764</orcidid><orcidid>https://orcid.org/0000-0003-0130-3778</orcidid><orcidid>https://orcid.org/0000-0002-3425-7758</orcidid><orcidid>https://orcid.org/0000-0002-7864-8187</orcidid><orcidid>https://orcid.org/0000-0003-2335-3792</orcidid><orcidid>https://orcid.org/0000-0002-6006-8328</orcidid></search><sort><creationdate>202502</creationdate><title>Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU</title><author>Mesonero, F. ; Zabana, Y. ; Fernández-Clotet, A. ; Solá, A. ; Caballol, B. ; Leo-Carnerero, E. ; García, M.J. ; Bertoletti, F. ; Bastida, G. ; Suris, G. ; Casis, B. ; Ferreiro-Iglesias, R. ; Calafat, M. ; Jiménez, I. ; Miranda-Bautista, J. ; Lamuela, L.J. ; Fajardo, I. ; Torrealba, L. ; Nájera, R. ; Sáiz-Chumillas, R.M. ; González-Partida, I. ; Vicuña, M. ; García-Morales, N. ; Gutiérrez, A. ; López-García, A. ; Benítez, J.M. ; Rubín de Célix, C. ; Tejido, C. ; Brunet, E. ; Hernandez-Camba, A. ; Suárez, C. ; Rodríguez-Lago, I. ; Piqueras, M. ; Castaño, A. ; Ramos, L. ; Sobrino, A. ; Rodríguez-Grau, M.C. ; Elosua, A. ; Montoro, M. ; Baltar, R. ; Huguet, J.M. ; Hermida, B. ; Caballero-Mateos, A. ; Sánchez-Guillén, L. ; Bouhmidi, A. ; Pajares, R. ; Baston-Rey, I. ; López-Sanromán, A. ; Albillos, A. ; Barreiro-de Acosta, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1503-df934c6b6ab45faed82abd52a46876173b564995289e1448183213d3a1f36d803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Colitis, Ulcerative - surgery</topic><topic>Colitis, Ulcerative - therapy</topic><topic>Colonic Pouches - adverse effects</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn's disease of the pouch</topic><topic>Cuffitis</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Italy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pouchitis</topic><topic>Pouchitis - drug therapy</topic><topic>Pouchitis - therapy</topic><topic>Proctocolectomy, Restorative - adverse effects</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mesonero, F.</creatorcontrib><creatorcontrib>Zabana, Y.</creatorcontrib><creatorcontrib>Fernández-Clotet, A.</creatorcontrib><creatorcontrib>Solá, A.</creatorcontrib><creatorcontrib>Caballol, B.</creatorcontrib><creatorcontrib>Leo-Carnerero, E.</creatorcontrib><creatorcontrib>García, M.J.</creatorcontrib><creatorcontrib>Bertoletti, F.</creatorcontrib><creatorcontrib>Bastida, G.</creatorcontrib><creatorcontrib>Suris, G.</creatorcontrib><creatorcontrib>Casis, B.</creatorcontrib><creatorcontrib>Ferreiro-Iglesias, R.</creatorcontrib><creatorcontrib>Calafat, M.</creatorcontrib><creatorcontrib>Jiménez, I.</creatorcontrib><creatorcontrib>Miranda-Bautista, J.</creatorcontrib><creatorcontrib>Lamuela, L.J.</creatorcontrib><creatorcontrib>Fajardo, I.</creatorcontrib><creatorcontrib>Torrealba, L.</creatorcontrib><creatorcontrib>Nájera, R.</creatorcontrib><creatorcontrib>Sáiz-Chumillas, R.M.</creatorcontrib><creatorcontrib>González-Partida, I.</creatorcontrib><creatorcontrib>Vicuña, M.</creatorcontrib><creatorcontrib>García-Morales, N.</creatorcontrib><creatorcontrib>Gutiérrez, A.</creatorcontrib><creatorcontrib>López-García, A.</creatorcontrib><creatorcontrib>Benítez, J.M.</creatorcontrib><creatorcontrib>Rubín de Célix, C.</creatorcontrib><creatorcontrib>Tejido, C.</creatorcontrib><creatorcontrib>Brunet, E.</creatorcontrib><creatorcontrib>Hernandez-Camba, A.</creatorcontrib><creatorcontrib>Suárez, C.</creatorcontrib><creatorcontrib>Rodríguez-Lago, I.</creatorcontrib><creatorcontrib>Piqueras, M.</creatorcontrib><creatorcontrib>Castaño, A.</creatorcontrib><creatorcontrib>Ramos, L.</creatorcontrib><creatorcontrib>Sobrino, A.</creatorcontrib><creatorcontrib>Rodríguez-Grau, M.C.</creatorcontrib><creatorcontrib>Elosua, A.</creatorcontrib><creatorcontrib>Montoro, M.</creatorcontrib><creatorcontrib>Baltar, R.</creatorcontrib><creatorcontrib>Huguet, J.M.</creatorcontrib><creatorcontrib>Hermida, B.</creatorcontrib><creatorcontrib>Caballero-Mateos, A.</creatorcontrib><creatorcontrib>Sánchez-Guillén, L.</creatorcontrib><creatorcontrib>Bouhmidi, A.</creatorcontrib><creatorcontrib>Pajares, R.</creatorcontrib><creatorcontrib>Baston-Rey, I.</creatorcontrib><creatorcontrib>López-Sanromán, A.</creatorcontrib><creatorcontrib>Albillos, A.</creatorcontrib><creatorcontrib>Barreiro-de Acosta, M.</creatorcontrib><creatorcontrib>On behalf of the GETECCU Young Members Group</creatorcontrib><creatorcontrib>GETECCU Young Members Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive and liver disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mesonero, F.</au><au>Zabana, Y.</au><au>Fernández-Clotet, A.</au><au>Solá, A.</au><au>Caballol, B.</au><au>Leo-Carnerero, E.</au><au>García, M.J.</au><au>Bertoletti, F.</au><au>Bastida, G.</au><au>Suris, G.</au><au>Casis, B.</au><au>Ferreiro-Iglesias, R.</au><au>Calafat, M.</au><au>Jiménez, I.</au><au>Miranda-Bautista, J.</au><au>Lamuela, L.J.</au><au>Fajardo, I.</au><au>Torrealba, L.</au><au>Nájera, R.</au><au>Sáiz-Chumillas, R.M.</au><au>González-Partida, I.</au><au>Vicuña, M.</au><au>García-Morales, N.</au><au>Gutiérrez, A.</au><au>López-García, A.</au><au>Benítez, J.M.</au><au>Rubín de Célix, C.</au><au>Tejido, C.</au><au>Brunet, E.</au><au>Hernandez-Camba, A.</au><au>Suárez, C.</au><au>Rodríguez-Lago, I.</au><au>Piqueras, M.</au><au>Castaño, A.</au><au>Ramos, L.</au><au>Sobrino, A.</au><au>Rodríguez-Grau, M.C.</au><au>Elosua, A.</au><au>Montoro, M.</au><au>Baltar, R.</au><au>Huguet, J.M.</au><au>Hermida, B.</au><au>Caballero-Mateos, A.</au><au>Sánchez-Guillén, L.</au><au>Bouhmidi, A.</au><au>Pajares, R.</au><au>Baston-Rey, I.</au><au>López-Sanromán, A.</au><au>Albillos, A.</au><au>Barreiro-de Acosta, M.</au><aucorp>On behalf of the GETECCU Young Members Group</aucorp><aucorp>GETECCU Young Members Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU</atitle><jtitle>Digestive and liver disease</jtitle><addtitle>Dig Liver Dis</addtitle><date>2025-02</date><risdate>2025</risdate><volume>57</volume><issue>2</issue><spage>566</spage><epage>573</epage><pages>566-573</pages><issn>1590-8658</issn><issn>1878-3562</issn><eissn>1878-3562</eissn><abstract>Inflammatory pouch disorders exhibit a heterogeneous clinical spectrum and therapeutic requirements have not been properly studied. This retrospective, multicentre study included ulcerative colitis patients with ileal pouch construction and were later diagnosed with an inflammatory pouch disorder between 1995 and 2020. Classifications, behaviour and therapies applied were recorded and compared in the long-term. Overall, 338 patients were recruited. The most common disorders were pouchitis (n = 258, 76%), Crohn's disease of the pouch (n = 55, 16%) and cuffitis (n = 25, 7%). Pouchitis presented mainly as chronic (65.2%) and recurrent (87%) forms. Crohn's disease manifested as stricturing/penetrating in 53% of cases and perianal disease in 42%. Patients received multiple therapies: 86% antibiotics, 42% steroids, 27% immunosuppressants, 43% biologics and 27% surgery. Compared with pouchitis, Crohn's disease of the pouch was characterised by a later diagnosis (99 vs. 55 months, p &lt; 0.001) and greater needs for immunosuppressants (OR 3.53, 1.79–6.94, p &lt; 0.0001), biologics (OR 5.45, 2.78–10.6, p &lt; 0.0001) and surgeries (OR 2.65, 1.43–4.89, p &lt; 0.001). Chronic pouchitis is the most common pouch disorder presentation. These entities have diverse therapeutics requirements, particularly for Crohn's disease of the pouch.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>39455313</pmid><doi>10.1016/j.dld.2024.09.023</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-1729-6472</orcidid><orcidid>https://orcid.org/0000-0003-0623-9074</orcidid><orcidid>https://orcid.org/0000-0001-6097-7612</orcidid><orcidid>https://orcid.org/0000-0002-7921-6730</orcidid><orcidid>https://orcid.org/0000-0001-7544-451X</orcidid><orcidid>https://orcid.org/0000-0001-7676-9842</orcidid><orcidid>https://orcid.org/0000-0002-5460-4139</orcidid><orcidid>https://orcid.org/0000-0002-3874-2638</orcidid><orcidid>https://orcid.org/0000-0001-8898-3141</orcidid><orcidid>https://orcid.org/0000-0002-6517-7005</orcidid><orcidid>https://orcid.org/0000-0002-0469-4332</orcidid><orcidid>https://orcid.org/0000-0003-1133-4578</orcidid><orcidid>https://orcid.org/0000-0002-8120-2485</orcidid><orcidid>https://orcid.org/0000-0001-9539-1689</orcidid><orcidid>https://orcid.org/0000-0001-8661-0608</orcidid><orcidid>https://orcid.org/0000-0001-7513-0764</orcidid><orcidid>https://orcid.org/0000-0003-0130-3778</orcidid><orcidid>https://orcid.org/0000-0002-3425-7758</orcidid><orcidid>https://orcid.org/0000-0002-7864-8187</orcidid><orcidid>https://orcid.org/0000-0003-2335-3792</orcidid><orcidid>https://orcid.org/0000-0002-6006-8328</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1590-8658
ispartof Digestive and liver disease, 2025-02, Vol.57 (2), p.566-573
issn 1590-8658
1878-3562
1878-3562
language eng
recordid cdi_proquest_miscellaneous_3121059732
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Anti-Bacterial Agents - therapeutic use
Colitis, Ulcerative - drug therapy
Colitis, Ulcerative - surgery
Colitis, Ulcerative - therapy
Colonic Pouches - adverse effects
Crohn Disease - drug therapy
Crohn's disease of the pouch
Cuffitis
Female
Humans
Immunosuppressive Agents - therapeutic use
Italy
Male
Middle Aged
Pouchitis
Pouchitis - drug therapy
Pouchitis - therapy
Proctocolectomy, Restorative - adverse effects
Retrospective Studies
title Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A32%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Types,%20behaviour%20and%20therapeutic%20requirements%20of%20inflammatory%20pouch%20disorders:%20Results%20from%20the%20RESERVO%20study%20of%20GETECCU&rft.jtitle=Digestive%20and%20liver%20disease&rft.au=Mesonero,%20F.&rft.aucorp=On%20behalf%20of%20the%20GETECCU%20Young%20Members%20Group&rft.date=2025-02&rft.volume=57&rft.issue=2&rft.spage=566&rft.epage=573&rft.pages=566-573&rft.issn=1590-8658&rft.eissn=1878-3562&rft_id=info:doi/10.1016/j.dld.2024.09.023&rft_dat=%3Cproquest_cross%3E3121059732%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3121059732&rft_id=info:pmid/39455313&rft_els_id=S1590865824010235&rfr_iscdi=true